The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Moshetova L.K.
Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch №1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001
Soshina M.M.
Russian Medical Academy of Continuous Professional Education, Department of Ophthalmology, 2/1 Barricadnaya St., Moscow, Russian Federation, 125993
Sychev D.A.
Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russia, Moscow, Russia
Turkina K.I.
Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 125993
Pharmacogenetics of timolol (in Russian only)
Journal: Russian Annals of Ophthalmology. 2019;135(3): 137‑143
Views: 3000
Downloaded: 111
To cite this article:
Moshetova LK, Soshina MM, Sychev DA, Turkina KI. Pharmacogenetics of timolol (in Russian only). Russian Annals of Ophthalmology.
2019;135(3):137‑143. (In Russ.)
https://doi.org/10.17116/oftalma2019135031137
In recent years, β-adrenergic blockers have become the first choice drugs for glaucoma treatment. Timolol holds the main position among them, being a part of most combined antiglaucoma preparations. The use of timolol maleate in clinical practice may be accompanied by severe side effects affecting different organs and systems. The fact that cells with β-adrenergic receptors are widely common within the human body explains pharmacodynamic effects of timolol maleate. Because of these undesirable side effects, timolol maleate often evokes negative reaction from doctors and patients, which to certain extent limits its usage in ophthalmological practice. Obviously, efficacy and safety of timolol administration depends on individual characteristics making personalized approach necessary for every patient. Such particular approach, being the foundation of personalized medicine, increases efficacy and safety of timolol while reducing costs by using targeted doses.
Authors:
Moshetova L.K.
Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch №1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001
Soshina M.M.
Russian Medical Academy of Continuous Professional Education, Department of Ophthalmology, 2/1 Barricadnaya St., Moscow, Russian Federation, 125993
Sychev D.A.
Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russia, Moscow, Russia
Turkina K.I.
Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 125993
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.